首页> 外文期刊>International Journal of Molecular Sciences >Glycosyltransferase GLT8D2 Positively Regulates ApoB100 Protein Expression in Hepatocytes
【24h】

Glycosyltransferase GLT8D2 Positively Regulates ApoB100 Protein Expression in Hepatocytes

机译:糖基转移酶GLT8D2积极调节肝细胞中ApoB100蛋白的表达

获取原文
           

摘要

Non-alcoholic fatty liver disease (NAFLD) is characterized by triglyceride (TG) accumulation in hepatocytes. Very low density lipoprotein (VLDL) is a major secretory product of the liver that transports endogenously synthesized TG. Disrupted VLDL secretion may contribute to the accumulation of TG in hepatocytes. ApoB100 (apolipoprotein B100) is a glycoprotein and an essential protein component of VLDL. Its glycosylation may affect VLDL assembly and secretion. However, which glycosyltransferase catalyzes apoB100 glycosylation is unknown. In this study, we cloned the GLT8D2 (glycosyltransferase 8 domain containing 2) gene from HepG2 cells and generated a series of plasmids for in vitro studies of its molecular functions. We discovered that GLT8D2 was localized in the ER, interacted with apoB100, and positively regulated the levels of apoB100 protein in HepG2 cells. Based on these results, we propose that GLT8D2 is a glycosyltransferase of apoB100 that regulates apoB100 levels in hepatocytes.
机译:非酒精性脂肪肝疾病(NAFLD)的特征是肝细胞中甘油三酸酯(TG)的积累。极低密度脂蛋白(VLDL)是肝脏的主要分泌产物,可转运内源性合成的TG。 VLDL分泌中断可能有助于TG在肝细胞中的积累。 ApoB100(载脂蛋白B100)是一种糖蛋白,是VLDL的重要蛋白成分。它的糖基化可能影响VLDL的组装和分泌。然而,哪种糖基转移酶催化apoB100糖基化是未知的。在这项研究中,我们从HepG2细胞克隆了GLT8D2(含2个糖基转移酶8结构域)基因,并生成了一系列质粒,用于对其分子功能的体外研究。我们发现,GLT8D2位于ER中,与apoB100相互作用,并且正调控HepG2细胞中apoB100蛋白的水平。基于这些结果,我们提出GLT8D2是apoB100的糖基转移酶,可调节肝细胞中apoB100的水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号